Biologic Nerve Repair for Morton’s Neuroma

“Biologics” refer to substances derived from living tissue — human, animal, or plant — that are used to influence how the body heals. In the context of nerve pain and nerve injury, biologics can help by:

• Reducing inflammation around the nerve
• Providing growth factors that support nerve tissue health
• Modulating the immune response that drives chronic pain
• Creating an environment that is less hostile to an injured or compressed nerve

For Morton’s neuroma and related foot nerve conditions, biologic treatments represent an evolving area of care that goes beyond cortisone shots and beyond surgery.

Several categories of biologic agents are being used or studied for nerve-related foot conditions. Each works differently and has a different evidence profile.

PRP is made from the patient’s own blood. A small sample is drawn, spun in a centrifuge to concentrate the platelets, and the resulting plasma is injected into or around the affected area. Platelets carry growth factors that can promote tissue repair and reduce chronic inflammation.

For Morton’s neuroma, PRP is injected using ultrasound guidance to place it precisely around the affected nerve. Some patients experience meaningful pain reduction, particularly those with early- to moderate-stage neuromas that have not responded to standard conservative care. PRP is less likely to help in cases where the nerve has already undergone significant fibrosis (scarring).

Wharton’s Jelly is a gelatinous tissue found in the umbilical cord. It is rich in mesenchymal stem cells, hyaluronic acid, collagen, and growth factors. When processed and injected, it delivers a concentrated package of healing signals directly to the target tissue.

Unlike PRP, Wharton’s Jelly is allogeneic — meaning it comes from a donor (consented, screened umbilical cord tissue) rather than the patient’s own blood. It provides a broader spectrum of biologic signals and has shown promise in reducing nerve inflammation and perineural fibrosis in some foot nerve conditions.

This treatment is not appropriate for all patients. Proper patient selection, ultrasound-guided delivery, and appropriate post-treatment management are all essential to achieving good results.

Amniotic membrane and placental tissue contain growth factors, anti-inflammatory cytokines, and extracellular matrix proteins that support tissue healing. These allografts — derived from donated birth tissue with informed consent — have been used in wound care and orthopedics for years and are now being applied to peripheral nerve conditions.

In foot nerve repair, amniotic tissue may be used as a perineural injection or as a wrap during nerve surgery to reduce scar formation around a repaired or decompressed nerve. The anti-scarring properties are particularly valuable in revision cases where previous surgery has already created adhesions around the nerve.

Peptides are short chains of amino acids that signal specific biological processes. Certain peptides have been studied for their ability to reduce neuroinflammation, promote nerve healing, and modulate pain signaling. While this area of research is still emerging, it represents one of the more promising frontiers in non-surgical nerve repair.

Peptide applications for foot nerve conditions are not yet mainstream and require a provider with specialized knowledge of both the science and the appropriate clinical context.

Biologic treatments are not appropriate for every patient with Morton’s neuroma or foot nerve pain. The best candidates are typically those who:

• Have not responded adequately to cortisone injections and standard conservative care
• Want to avoid surgery or are not surgical candidates
• Have ongoing pain despite a previous neuroma surgery
• Have a nerve that is injured or inflamed but not yet so severely scarred that it cannot respond to healing signals
• Are in good general health and do not have conditions that would impair the biologic response

Biologics are generally not the right choice when:

• The nerve has been completely removed (neurectomy) — there is no nerve to treat
• A stump neuroma has formed and requires surgical intervention
• There is a mechanical cause (such as severe metatarsal deformity) that cannot be addressed without surgery
• The patient has an active infection or immune condition that would affect healing

A thorough evaluation — including diagnostic ultrasound — is necessary before recommending any biologic treatment.

Precision matters enormously with biologic injections. The nerve is a small, mobile structure, and placing the biologic material accurately — in the right plane, at the right depth — is essential for clinical benefit. At this practice, all perineural biologic injections are performed under real-time ultrasound guidance.

This means the provider can:

• Visualize the nerve and the surrounding tissue in real time
• Confirm needle placement before delivering the biologic agent
• Avoid inadvertent intraneural injection, which can damage the nerve
• Ensure the material is distributed appropriately around the target structure

Ultrasound-guided delivery is not a standard feature of every injection practice. It requires specialized training and equipment, and it significantly improves both safety and outcomes.

Biologic nerve repair is not an instant fix. Unlike corticosteroids, which reduce inflammation quickly (and often temporarily), biologics work over time by supporting a healing process. Most patients should expect:

• First 1–2 weeks: Some soreness or mild flare at the injection site is normal. Avoid anti-inflammatory medications (NSAIDs) during this period, as they can interfere with the biologic response.
• Weeks 2–6: Gradual improvement in pain and nerve sensitivity. Some patients notice improvement in this window; others take longer.
• Months 2–3: The full effect of the treatment becomes clearer. For some patients, a second treatment may be appropriate at this stage.

Results vary. Biologics are not a guaranteed solution, and they work best as part of a comprehensive nerve care plan that includes appropriate footwear modifications, offloading strategies, and follow-up evaluation.

One of the most meaningful applications for biologic nerve therapies is in patients who have already had surgery and are still in pain.

After neurectomy (nerve removal), a stump neuroma may form at the cut end of the nerve. After decompression surgery, scar tissue can re-entrap the nerve. In both situations, the nerve environment is hostile — filled with fibrosis, aberrant nerve growth, and dysregulated pain signals.

Biologic agents — particularly amniotic tissue and Wharton’s Jelly — may help reduce inflammation and fibrosis in the perineural space, potentially improving the nerve environment enough to reduce pain without requiring additional surgery. In some revision surgical cases, biologics are used intraoperatively to wrap the repaired nerve and reduce the chance of re-scarring.

This is highly specialized work. It requires an understanding of nerve biology, surgical anatomy, and the evidence base for each biologic product — not just access to the products themselves.

Biologic treatments for nerve conditions are being offered by a growing number of providers, not all of whom have the training or diagnostic infrastructure to use them appropriately. Without proper evaluation, a biologic injection may be directed at the wrong structure, delivered in the wrong plane, or used in a patient who would be better served by a different approach entirely.

Dr. Bregman is a podiatric surgeon with specialized training in nerve surgery and perineural pathology. He evaluates patients with foot nerve conditions — including those who have already had treatments elsewhere — using clinical examination and diagnostic ultrasound, and recommends treatment based on what the nerve actually needs, not on what happens to be available.

Biologic nerve repair is one tool in that evaluation — used when it is the right tool, and not when it isn’t.

If you have Morton’s neuroma or foot nerve pain that has not responded to standard treatment, a specialist evaluation can help clarify whether biologic nerve repair — or another approach — is appropriate for your specific situation.

Dr. Bregman evaluates patients from throughout the region and accepts complex cases, including those involving prior surgery or failed prior treatment.visit our contact page to request a consultation.

Patients who have had a Morton’s neuroma surgically removed and are still experiencing pain may have developed a stump neuroma — a different condition that requires its own evaluation and treatment approach. Biologic therapies may play a supportive role in some of these cases. Learn more on the Stump Neuroma page.